{{Rsnum
|rsid=718768
|Gene=EGF
|Chromosome=4
|position=109902959
|Orientation=minus
|GMAF=0.191
|Gene_s=EGF
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.0 | 36.6 | 55.4
| HCB | 0.0 | 12.5 | 87.5
| JPT | 0.0 | 12.5 | 87.5
| YRI | 5.4 | 30.6 | 63.9
| ASW | 5.3 | 31.6 | 63.2
| CHB | 0.0 | 12.5 | 87.5
| CHD | 0.0 | 10.1 | 89.9
| GIH | 6.9 | 33.7 | 59.4
| LWK | 0.9 | 20.9 | 78.2
| MEX | 3.4 | 32.8 | 63.8
| MKK | 1.3 | 23.1 | 75.6
| TSI | 7.8 | 43.1 | 49.0
| HapMapRevision=28
}}Common genetic variability in [[ESR1]] and [[EGF]] in relation to endometrial cancer risk and survival. {{PMID|19319135|OA=1
}}

Development of predictive models of proliferative vitreoretinopathy based on genetic variables: the Retina 4 project. {{PMID|19098314}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}